Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Except for the announcement that dosing has started in the first 2 patients in this Phase 1 trial, there wasn't anything new in today's news release. We already new this trial was active and recruiting. So not much news to try to sell into today, unfortunately.
